Palisade Bio (PALI) Other Working Capital Changes (2010 - 2022)
Palisade Bio (PALI) posted quarterly Other Working Capital Changes of $127000.0 for Q3 2025, up 496.88% year-over-year from $21277.5 in Q3 2024, and up 473.53% quarter-over-quarter from -$34000.0 in Q2 2025.
Powered by 
Analysis
Palisade Bio (PALI) Other Working Capital Changes (2010 - 2022) Analysis & Trends
Palisade Bio (PALI) has reported Other Working Capital Changes for 13 consecutive years, with $127000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Working Capital Changes rose 496.88% year-over-year to $127000.0; the TTM figure through Mar 2026 stood at $93000.0 (up 2425.0% YoY), while the FY2025 annual figure was $61000.0, changed N/A from the prior year.
- Other Working Capital Changes rose to $127000.0 in Q3 2025 per PALI's latest filing, from -$34000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $519000.0 in Q3 2025 and bottomed at -$1.1 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$178411.8 across 5 years, with a median of -$175000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 1682.61% — and 2025, when it soared 496.88%.
- Palisade Bio's Other Working Capital Changes stood at $23000.0 in 2021, then plunged by 1682.61% to -$364000.0 in 2022, then surged by 143.41% to $158000.0 in 2023, then sank by 43.67% to $89000.0 in 2024, then jumped by 42.7% to $127000.0 in 2025.
- Business Quant data shows PALI's Other Working Capital Changes at $127000.0 in Q3 2025, -$34000.0 in Q2 2025, and -$32000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Sep 30, 2021 | -374,000.00 |
| Sep 30, 2021 | -374,000.00 |
| Sep 30, 2012 | 177,445.00 |
| Sep 30, 2012 | 177,445.00 |
| Sep 30, 2011 | -6,243.00 |
| Sep 30, 2011 | -6,243.00 |
| Jun 30, 2011 | 6,243.00 |
| Jun 30, 2011 | 6,243.00 |
| Mar 31, 2011 | -322,127.00 |
| Mar 31, 2011 | -322,127.00 |
| Dec 31, 2010 | 333,593.00 |
| Dec 31, 2010 | 333,593.00 |